Clinical Trials Directory

Trials / Completed

CompletedNCT02060682

Post-Market Registry of the ACIST CPM System and Navvus Catheter in Clinical Practice

Post-Market Registry of the ACIST Cardiovascular Pressure Measurement (CPM) System and Navvus Catheter in Clinical Practice-ADVANCE-EU

Status
Completed
Phase
Study type
Observational
Enrollment
60 (actual)
Sponsor
Acist Medical Systems · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This registry will collect real-world clinical evidence on the performance, safety, and usability of the ACIST CPM System and NAVVUS Catheter when used in accordance with approved labeling in a European commercial setting. Up to 60 subjects will have Fractional Flow Reserve (FFR) measurements of coronary lesions attempted with the CPM System and NAVVUS Catheter. All subjects will receive diagnostic treatment according to clinical indications and center standard practice.

Detailed description

There are no protocol-specific procedural requirements for this registry. Enrolled subjects will undergo a diagnostic angiography procedure including an FFR measurement with the CPM System and NAVVUS Catheter according to the center standard of care and the Instructions for Use of the CPM System and Navvus Catheter. Participants will be followed for the duration of hospital stay, an expected average of 1 day.

Conditions

Interventions

TypeNameDescription
DEVICENavvus Catheter FFRNavvus Catheter provides Fractional Flow Reserve (FFR) measurement for each lesion identified according to standard of care of the center and the Instructions for Use (IFU).

Timeline

Start date
2014-02-01
Primary completion
2014-07-01
Completion
2014-07-01
First posted
2014-02-12
Last updated
2019-12-09

Locations

7 sites across 4 countries: France, Germany, Italy, Spain

Source: ClinicalTrials.gov record NCT02060682. Inclusion in this directory is not an endorsement.